Indeed, tumoral programmed cell death-ligand 1 (PD-L1) expression has been observed in thyroid carcinomas (80, 81) and has been associated with increased risk of recurrence and poor prognosis (81, 82). Here, CD274 is linked to thyroid gland carcinoma.